Where is Acandis located?

Acandis is headquartered in Germany.

Who is the current CEO of Acandis?

Kirsi Schuessler of Acandis. They have also founded 1 company.

Which legal entities is Acandis associated with?

Acandis is associated with Acandis Gmbh and 2 others.

How many employees does Acandis have?

As of Jun 30, 2026, the latest employee count at Acandis is 203.

Is Acandis a funded company?

Acandis is a funded company, having raised a total of $***** in its 1st and only funding round.

What is the annual revenue of Acandis?

Annual revenue of Acandis is between €10M and €50M as on Dec 31, 2021

Where does Acandis rank among its competitors?

Acandis ranks 14th amongst 60 active competitors, of which 20 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was XCath, which secured $30M in Mar, 2026.

Who are the top competitors of Acandis?

Acandis' top competitors include Rapid Medical, Penumbra and Anaconda Biomed. Among them, XCath secured the most recent funding round in March, 2026.

Acandis - 2026 Company Profile, Team, Funding, Competitors & Financials

Acandis is a funded company based in Germany, founded in 2006 by Kirsi Schuessler. It operates as a Developer of medical devices for hemorrhagic and ischemic stroke treatment. The company has 60 active competitors, including 20 funded and 15 that have exited. Its top competitors include companies like Rapid Medical, Penumbra and Anaconda Biomed.

Company Details

Developer of medical devices for hemorrhagic and ischemic stroke treatment. The company offers devices for embolization and thrombectomy. It provides solutions for access and delivery, along with devices for visceral aneurysms. The company is involved in research, education, training services, publications, and clinical studies.

Website: acandis.com
Social
Email ID: *****@acandis.com
Phone Number: +49 **********

Key Metrics

Founded Year

2006

Location

Germany

Stage

Funding Raised

Investors

S-Kap & 1 more

Ranked

14^th among 60 active competitors

Annual Revenue

€10M - €50M as on Dec 31, 2021

Employee Count

203 as on Jun 30, 2026

Similar Companies

Rapid Medical & 53 more

View Acandis' full profile

Acandis is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ACANDIS INC CIN: 883280125 , United States, Active	Dec 31, 1999	-	2 (As on Dec 31, 2022)	-
ACANDIS GMBH CIN: 39.915.594/0001-04 , Brazil, Active	Nov 25, 2020	-	-	-
Acandis Gmbh CIN: HRB727935 , Germany, Active	Aug 05, 2017	€10M - €50M (As on Dec 31, 2021)	240 (As on Dec 31, 2023)

Acandis is a funded company. Acandis has 2 institutional investors.

View details of Acandis's funding rounds and investors

The founders of Acandis is Kirsi Schuessler. Kirsi Schuessler is the CEO of Acandis.

Here are the details of Acandis' key team members:

Kirsi Schuessler: Owner & Co-CEO & Managing Director of Acandis.
Contact Info: 1 email address

Acandis' Board of Directors

Acandis's board has 1 active member. Michael Hannus is independent board member.

Here is the list of Acandis' board of directors:

Name	Type	Representing	Status	Duration
Michael Hannus	Independent board member	-	Current	12y 8m

View details of Acandis's Founder profiles and Board Members

Acandis' employee count trend

Acandis has 203 employees as of Jun 26. Here is Acandis's employee count trend over the years:

Uncover Acandis' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Acandis include Rapid Medical, Penumbra and Anaconda Biomed. Here is the list of Top 10 competitors of Acandis, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Rapid Medical 2008, Yokneam Illit (Israel), Series D	Developer of neurovascular interventional devices such as distal access & microcatheters	$79M	MicroPort Orthopedics, BRM & 9 others	64/100
2nd	Penumbra 2004, Alameda (United States), Acquired	Developer of medical devices for neurovascular and peripheral thrombectomy	$121K	Novo Holdings, The Angels’ Forum & 4 others	63/100
3rd	Anaconda Biomed 2015, Barcelona (Spain), Series B	Developer of medical devices for mechanical thromboectomy procedures	$39M	Omega Funds, Ysios Capital & 6 others	55/100
4th	XCath 2017, Houston (United States), Series C	Developer of endovascular robotics and steerable guidewires	$92M	Crescent Enterprises & 1 others	49/100
5th	Sequent Medical 2007, Aliso Viejo (United States), Acquired	Catheter-based neurovascular devices	$65.3M	Delphi Ventures, Versant Ventures & 4 others	48/100
6th	Terumo Neuro 1997, Aliso Viejo (United States), Unfunded	Developer of minimally-invasive devices for the treatment of vascular diseases in the brain	-	-	46/100
7th	MicroVention 1997, Tustin (United States), Acquired	Innovative neurovascular solutions for hemorrhagic and ischemic stroke treatment	-	Domain Associates, Advanced Technology Ventures ... & 4 others	45/100
8th	BrainsGate 2000, Caesarea (Israel), Series F	Electrical stimulation therapy for CNS diseases	$97M	BNP Paribas, Cipio Partners & 11 others	44/100
9th	Galaxy Therapeutics 2012, Milpitas (United States), Funding Raised	Developer of neurovascular devices to treat brain aneurysms	-	National Science Foundation	44/100
10th	N Focus Neuro 2007, Palo Alto (United States), Acquired	Endovascular neurosurgery solutions for the treatment of intracranial aneurysms	$37M	VentureHealth, Endeavour Vision & 5 others	43/100
14th	Acandis 2006, Germany, Funding Raised	Developer of medical devices for hemorrhagic and ischemic stroke treatment	-	S-Kap & 1 others	41/100